Unknown

Dataset Information

0

The Association of PPAR? Pro12Ala and C161T Polymorphisms with Polycystic Ovary Syndrome and Their Influence on Lipid and Lipoprotein Profiles.


ABSTRACT: Background:The aim of present study was to clarify the role of the peroxisome proliferator-activated receptor (PPAR) ? Pro12Ala and C161T polymorphisms in the pathogenesis of polycystic ovary syndrome (PCOS) and their influence on lipid and lipoprotein profiles of patients. MATERIALS AND METHODS:The present cross-sectional study consisted of 50 women with PCOS, who referred to the Kermanshah University of Medical Sciences Clinic between April and October 2015, and 233 unrelated age-matched healthy women from the same region (West Iran). The PPAR? Pro12Ala and PPAR? C161T polymorphisms were genotyped using the polymerase chain reaction-restriction fragment length polymorphism method. Fasting blood sugar (FBS), serum triglycerides (TG), cholesterol, low density lipoprotein- cholesterol (LDL-C), high density lipoproteincholesterol (HDL-C) and estradiol levels were measured. RESULTS:The serum level of estradiol was significantly lower in PCOS patients compared to healthy women. The PPAR? Pro12Ala (CG) genotype increased the risk of PCOS 2.96-fold. The frequency of the PPAR? T allele (at C161T) was 21% in patients and 17.2% in controls with no significant difference (P=0.52). In all studied individuals, the PPAR? CG genotype was associated with significantly higher levels of TG. However, significantly lower levels of total cholesterol and LDL-C were observed in PPAR? TT individuals compared with those with the CC genotype. Within the PCOS group, the PPAR? CG genotype was significantly associated with lower levels of estradiol compared with the CC genotype. Also, the CG genotype was significantly associated with higher levels of TG when compared with the CC genotype. CONCLUSION:Our study shows that, unlike PPAR? C161T, PPAR? Pro12Ala is associated with the risk of PCOS. Also, we found that the lipid and lipoprotein profiles significantly vary based on PPAR? Pro12Ala and C161T genotypes.

SUBMITTER: Rahimi Z 

PROVIDER: S-EPMC5936613 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

The Association of PPARγ Pro12Ala and C161T Polymorphisms with Polycystic Ovary Syndrome and Their Influence on Lipid and Lipoprotein Profiles.

Rahimi Zohreh Z   Chamaie-Nejad Foroogh F   Saeidi Shohreh S   Rahimi Ziba Z   Ebrahimi Ali A   Shakiba Ebrahim E   Vaisi-Raygani Asad A  

International journal of fertility & sterility 20180318 2


<h4>Background</h4>The aim of present study was to clarify the role of the peroxisome proliferator-activated receptor (PPAR) γ Pro12Ala and C161T polymorphisms in the pathogenesis of polycystic ovary syndrome (PCOS) and their influence on lipid and lipoprotein profiles of patients.<h4>Materials and methods</h4>The present cross-sectional study consisted of 50 women with PCOS, who referred to the Kermanshah University of Medical Sciences Clinic between April and October 2015, and 233 unrelated ag  ...[more]

Similar Datasets

| S-EPMC5937197 | biostudies-literature
| S-EPMC3401263 | biostudies-literature
| S-EPMC3070246 | biostudies-literature
| S-EPMC7182264 | biostudies-literature
| S-EPMC4529894 | biostudies-literature
| S-EPMC3295652 | biostudies-literature
| S-EPMC10739822 | biostudies-literature
| S-EPMC6379247 | biostudies-literature
| S-EPMC7203813 | biostudies-literature
| S-EPMC3599233 | biostudies-literature